275 related articles for article (PubMed ID: 11259390)
41. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
[TBL] [Abstract][Full Text] [Related]
42. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
43. Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells.
Tyler A; Johansson A; Karlsson T; Gudey SK; Brännström T; Grankvist K; Behnam-Motlagh P
Exp Cell Res; 2015 Aug; 336(1):23-32. PubMed ID: 26004871
[TBL] [Abstract][Full Text] [Related]
44. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
45. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
Lucci A; Giuliano AE; Han TY; Dinur T; Liu YY; Senchenkov A; Cabot MC
Int J Oncol; 1999 Sep; 15(3):535-40. PubMed ID: 10427136
[TBL] [Abstract][Full Text] [Related]
46. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
47. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P
Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984
[TBL] [Abstract][Full Text] [Related]
48. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
[TBL] [Abstract][Full Text] [Related]
49. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
Klement G; Huang P; Mayer B; Green SK; Man S; Bohlen P; Hicklin D; Kerbel RS
Clin Cancer Res; 2002 Jan; 8(1):221-32. PubMed ID: 11801563
[TBL] [Abstract][Full Text] [Related]
50. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
51. [Effects of artificial microRNA targeting glucosylceramide synthase on drug sensitivity of breast cancer cells].
Sun YL; Gao P; Zhang XF; Gao YS; Zhou GY
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3296-9. PubMed ID: 23328518
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.
Roh JL; Kim EH; Park JY; Kim JW
Mol Cancer Ther; 2015 Aug; 14(8):1907-15. PubMed ID: 26063766
[TBL] [Abstract][Full Text] [Related]
53. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells.
Ponnapakam AP; Liu J; Bhinge KN; Drew BA; Wang TL; Antoon JW; Nguyen TT; Dupart PS; Wang Y; Zhao M; Liu YY; Foroozesh M; Beckman BS
Bioorg Med Chem; 2014 Feb; 22(4):1412-20. PubMed ID: 24457089
[TBL] [Abstract][Full Text] [Related]
54. Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.
Khiste SK; Hosain SB; Dong Y; Uddin MB; Roy KR; Hill RA; Liu Z; Liu YY
Sci Rep; 2017 Jun; 7(1):2976. PubMed ID: 28592871
[TBL] [Abstract][Full Text] [Related]
55. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
[TBL] [Abstract][Full Text] [Related]
56. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
[TBL] [Abstract][Full Text] [Related]
57. Glucosylceramide synthase and apoptosis.
Bleicher RJ; Cabot MC
Biochim Biophys Acta; 2002 Dec; 1585(2-3):172-8. PubMed ID: 12531551
[TBL] [Abstract][Full Text] [Related]
58. Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel.
Giussani P; Bassi R; Anelli V; Brioschi L; De Zen F; Riccitelli E; Caroli M; Campanella R; Gaini SM; Viani P; Riboni L
Cancer Invest; 2012 Jan; 30(1):27-37. PubMed ID: 22236187
[TBL] [Abstract][Full Text] [Related]
59. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
Gouazé-Andersson V; Yu JY; Kreitenberg AJ; Bielawska A; Giuliano AE; Cabot MC
Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065
[TBL] [Abstract][Full Text] [Related]
60. Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
Gupta V; Patwardhan GA; Zhang QJ; Cabot MC; Jazwinski SM; Liu YY
J Lipid Res; 2010 Apr; 51(4):866-74. PubMed ID: 19826105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
